← Back to Search

Augmented Reality Rehabilitation for Stroke-Related Neglect

N/A
Recruiting
Led By Murat Akcakaya, PhD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
acute stroke
intact auditory function (positive test on Auditory Sensation Test)
Must not have
current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor
inability to follow one-step directions at least 80% of the time
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 4
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new tool to help people with neglect, a condition where they don't pay attention to one side of their body. The tool uses augmented reality and EEG to help detect and rehabilitate neglect.

Who is the study for?
This trial is for adults over 18 who've had a stroke and are in inpatient rehab. They must have trouble noticing things on one side (neglect), be able to hear well, respond to vibrations, speak English, and miss targets in an AR test. People with dementia, Parkinson's disease, MS, brain tumors or metal implants that affect EEGs can't join.
What is being tested?
The study is testing a new tool that uses augmented reality (AR) and brainwave monitoring (EEG) to find out if someone has neglect after a stroke and help them recover. Participants will use this AR system as part of their rehabilitation therapy.
What are the potential side effects?
Since the intervention involves non-invasive AR and EEG technology for assessment and rehabilitation purposes rather than medication or surgery, significant side effects are not expected. However, some participants may experience discomfort from wearing the EEG cap or fatigue from the tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a recent stroke.
Select...
My hearing is normal according to a hearing test.
Select...
I am 18 years old or older.
Select...
I am currently in a rehabilitation program as an inpatient.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with dementia, Parkinson's, multiple sclerosis, or have a brain tumor.
Select...
I struggle to follow simple instructions most of the time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Accuracy; indicated by percent agreement between participant report and EEG-based assessment of neglect
Reliability; indicated by correlation coefficient between two consecutive sessions of EEG recording
Secondary study objectives
Program Satisfaction; indicated by mean score of 3 or greater on the Client Satisfaction Questionnaire
Technology Satisfaction; indicated by a mean score of 3 or higher on the Quebec User Evaluation of Satisfaction with Assistive Technology

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: augmented realityExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,792 Previous Clinical Trials
16,359,976 Total Patients Enrolled
28 Trials studying Stroke
2,891 Patients Enrolled for Stroke
Northeastern UniversityOTHER
99 Previous Clinical Trials
71,066 Total Patients Enrolled
4 Trials studying Stroke
537 Patients Enrolled for Stroke
NSFUNKNOWN
Murat Akcakaya, PhDPrincipal Investigator - University of Pittsburgh
University of Pittsburgh

Media Library

augmented reality Clinical Trial Eligibility Overview. Trial Name: NCT04187131 — N/A
Stroke Research Study Groups: augmented reality
Stroke Clinical Trial 2023: augmented reality Highlights & Side Effects. Trial Name: NCT04187131 — N/A
augmented reality 2023 Treatment Timeline for Medical Study. Trial Name: NCT04187131 — N/A
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top